Summit is new name for VASTox
Summit Corporation plc announced that the Company's name change from VASTox plc has been completed.
The Company decided to change its name from VASTox to Summit following a period of growth and development that saw it both enhance its drug pipeline and strengthen its core technology capabilities internally and through its recent acquisitions. The new name aims to encapsulate the ambitions of the Company and to provide an identity that has the flexibility to accommodate the future growth and development of the business. The change of name was approved by shareholders at the Company's AGM on 19 July 2007.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Two-pronged attack on chemotherapy-resistant leukemia cells

How antibiotic resistance persists thanks to selfish genetic elements - Research team shows mechanisms which enable bacteria to maintain resistance, even under non-selective conditions
Category:Semisynthetic_opioids
Crucell and DSM Announce PER.C6® Licensing Agreement with Chiron
Dichloroisocyanuric_acid
United_States_Army_Soldier_Systems_Center
EDTA
